Monoclonal antibodies in the treatment of chronic lymphoid leukemias. [electronic resource]
Producer: 20040728Description: 205-19 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Aged, 80 and over
- Alemtuzumab
- Animals
- Antibodies, Monoclonal -- metabolism
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antibodies, Neoplasm -- pharmacology
- Antigens, CD -- biosynthesis
- Antigens, CD19 -- biosynthesis
- Antigens, CD20 -- biosynthesis
- Antigens, Differentiation, B-Lymphocyte -- biosynthesis
- Antigens, Neoplasm -- biosynthesis
- Antineoplastic Combined Chemotherapy Protocols
- CD5 Antigens -- biosynthesis
- CD52 Antigen
- Cell Adhesion Molecules
- Cell Membrane -- metabolism
- Combined Modality Therapy
- Glycoproteins -- biosynthesis
- Humans
- Immunotherapy -- methods
- Lectins -- biosynthesis
- Leukemia, B-Cell -- therapy
- Leukemia, Hairy Cell -- therapy
- Leukemia, Lymphocytic, Chronic, B-Cell -- therapy
- Leukemia, Myeloid -- therapy
- Lymphatic Metastasis
- Lymphocytes -- metabolism
- Middle Aged
- Pentostatin -- pharmacology
- Rats
- Rituximab
- Sialic Acid Binding Ig-like Lectin 2
- Simplexvirus -- metabolism
- Stem Cell Transplantation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.